FDA Adverse Event Injury Summary report: N

ALLIANCE REVISION HIP SYSTEM

MDR report key: 6937661 · Received October 10, 2017

Report

Report Number
0001825034-2017-08404
Event Type
Injury
Date Received
October 10, 2017
Report Date
October 10, 2017
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KWA
PMA / PMN Number
PN/A
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

WALLNER, O., STARK, A., MUREN, OL, EISLER, T., SKOLDENBERG, O. (2014) UNSTABLE HIP ARTHROPLASTIES. A PROSPECTIVE COHORT STUDY ON SEVENTY DISLOCATING HIPS FOLLOWED UP FOR FOUR YEARS. INTERNATIONAL ORTHOPAEDICS (SICOT), DOI 10.1007/S00264-014-2583-8. RECEIVED: 9 OCTOBER 2014/ACCEPTED: 23 OCTOBER 2014. THE PRODUCT WAS NOT AVAILABLE FOR RETURN. CONDITION IS ADDRESSED IN THE PACKAGE INSERT. WITHOUT THE OPPORTUNITY TO EXAMINE THE COMPLAINT PRODUCT, ROOT CAUSE CANNOT BE DETERMINED. PART AND LOT IDENTIFICATION ARE NECESSARY FOR REVIEW OF DEVICE HISTORY RECORDS AND COMPLAINT HISTORY, NEITHER WERE PROVIDED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 1

INFORMATION WAS RECEIVED BASED ON REVIEW OF A JOURNAL ARTICLE TITLED, "UNCEMENTED UNSTABLE HIP ARTHROPLASTIES. A PROSPECTIVE COHORT STUDY ON SEVENTY DISLOCATING HIPS FOLLOWED UP FOR FOUR YEARS." THE ARTICLE IDENTIFIED A (B)(6) OLD MALE THAT HAD A DISLOCATION 75 DAYS POST HIP ARTHROPLASTY. FOLLOWING THIS SAME (B)(6) OLD MALE HAD ANOTHER DISLOCATION ON AN UNKNOWN DATE. BOTH DISLOCATIONS WERE TREATED WITH A CLOSED REDUCTION. THIS PATIENT WAS FOLLOWED FOR FIVE (5) YEARS. NO FURTHER INFORMATION WAS PROVIDED AND THE PATIENT'S OUTCOME IS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
715112 ALLIANCE REVISION HIP SYSTEM PROSTHESIS - HIP KWA ZIMMER BIOMET, INC. N/A UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 75 YR Required Intervention